ArticleClinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico2026
Predicting time to local failure after gamma knife radiosurgery for melanoma brain metastases using survival machine learning.
Article in Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMelanoma brain metastases treated with Gamma Knife radiosurgery show heterogeneous local control trajectories. Accurate prediction of time to local control loss could support risk stratification and follow-up planning using routinely available clinical and treatment variables.
methodsA retrospective dataset was constructed from a melanoma brain metastasis radiosurgery cohort. The endpoint was time to local control loss with right censoring for lesions maintaining local control at last follow-up. Clinical, demographic, and treatment features were included, focusing on age, sex, race, pre-treatment KPS, systemic therapy, number of metastases, lesion location, eloquence, tumor volume, and margin dose. A Random Survival Forest model was trained using one-hot encoding for categorical variables. Performance was assessed with five-fold stratified cross-validation at the lesion-level using Harrell C index. Feature importance was estimated with permutation importance.
resultsA total of 884 lesions were analyzed, including 198 local control loss events. The Random Survival Forest achieved high discrimination with a mean C index of 0.919 ± 0.020 across folds. The most influential predictors were age at treatment, margin dose, pre-treatment KPS, tumor volume, and isodose line. Additional contributions were observed from anatomic location and therapy category.
conclusionsA Random Survival Forest survival model accurately predicted time to local control loss in melanoma brain metastases using routinely collected variables, with strong discrimination and transparent feature importance. This approach enables individualized risk estimation and time-based predictions that can be integrated into clinical decision support and follow-up strategies.
Indexed as
Identifiers
42251631What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.